ArticlebioRxiv : the preprint server for biology2026
Automated Cyclic Super-Resolution Microscopy for Nanoscale Protein Mapping.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nanoscale mapping of multiple molecular targets is essential for decoding cellular architecture, but current approaches are limited by low throughput, intensive manual intervention, and signal variability across imaging cycles. Here, we introduce CycSTORM, an integrated super-resolution imaging platform for automated cyclic (d)STORM that enables multiplexed nanoscale protein mapping in single cells. To overcome the instability inherent in multi-day imaging, CycSTORM combines automated fluidic exchange, active 3D drift correction, and an oxygen-excluded imaging environment to stabilize fluorophore blinking and enables sub-5 nm registration across day-long experiments. Furthermore, CycSTORM incorporates a rapid chemical inactivation step using meta-chloroperoxybenzoic acid (mCPBA), eliminating >99.9% residual fluorescence within 10 minutes and minimizing inter-cycle crosstalk while preserving sample integrity. By standardizing labeling to Alexa Fluor 647, a fluorophore with stable and well-characterized blinking behavior, CycSTORM minimizes fluorophore-dependent variation and provides a robust platform for consistent localization precision across cycles, enabling reliable mapping of protein organization in single cells. Using CycSTORM, we simultaneously map multiple protein targets within the same cells with nanometer precision. Together, these advances transform cyclic super-resolution imaging into a scalable approach for quantitative nanoscale mapping of molecular organization in single cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.